Clinical Trial Update: Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for fluzoparib in patients with metastatic non-clear cell renal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Fluzoparib (fluzoparib)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Renal Cell Carcinoma | Phase 2 | Status: COMPLETED